High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19

INTRODUCTION: High-flow nasal cannula oxygen therapy (HFNC) has been shown to be a useful therapy in the treatment of patients with Acute Respiratory Distress Syndrome (ARDS), but its efficacy is still unknown in patients with COVID-19. Our objective is to describe its utility as therapy for the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Panadero, Carolina, Abad-Fernández, Araceli, Rio-Ramirez, Mª Teresa, Acosta Gutierrez, Carmen Maria, Calderon-Alcala, Mariara, Lopez-Riolobos, Cristina, Matesanz-Lopez, Cristina, Garcia-Prieto, Fernando, Diaz-Garcia, Jose Maria, Raboso-Moreno, Beatriz, Vasquez-Gambasica, Zully, Andres-Ruzafa, Pilar, Garcia-Satue, Jose Luis, Calero-Pardo, Sara, Sagastizabal, Belen, Bautista, Diego, Campos, Alfonso, González, Marina, Grande, Luis, Jimenez Fernandez, Marta, Santiago-Ruiz, Jose L., Caravaca Perez, Pedro, Alcaraz, Andres Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512942/
https://www.ncbi.nlm.nih.gov/pubmed/32983456
http://dx.doi.org/10.4081/mrm.2020.693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512942/
https://www.ncbi.nlm.nih.gov/pubmed/32983456
http://dx.doi.org/10.4081/mrm.2020.693

Ejemplares similares